The Hypothetical Rabbit

Por Kattan, Michael W.
Publicado no Front Oncol (2016)

Formalized prediction of clinically significant prostate cancer: is it possible?

Por Nguyen, Carvell T, Kattan, Michael W
Publicado em 2012

The Use of Nomograms for Selecting BPH Candidates for Dutasteride Therapy

Por Slawin, Kevin M, Kattan, Michael W
Publicado em 2004

On Risk Estimation versus Risk Stratification in Early Prostate Cancer

Por Carlsson, Sigrid V., Kattan, Michael W.
Publicado no PLoS Med (2016)

Modeling Potential Time to Event Data with Competing Risks

Por Li, Liang, Hu, Bo, Kattan, Michael W.
Publicado em 2013

Prostate Cancer Screening: A Brief Tool to Incorporate Patient Preferences in a Clinical Encounter

Por Misra-Hebert, Anita D., Kattan, Michael W.
Publicado no Front Oncol (2016)

Method for evaluating prediction models that apply the results of randomized trials to individual patients

Por Vickers, Andrew J, Kattan, Michael W, Sargent, Daniel
Publicado em 2007

Against Diagnosis

Por Vickers, Andrew J., Basch, Ethan, Kattan, Michael W.
Publicado em 2008

Predicting an Optimal Outcome after Radical Prostatectomy: The “Trifecta” Nomogram

Por Eastham, James A., Scardino, Peter T., Kattan, Michael W.
Publicado no J Urol (2008)

Modeling Individual Patient Preferences for Colorectal Cancer Screening Based on Their Tolerance for Complications Risk

Por Taksler, Glen B., Perzynski, Adam T., Kattan, Michael W.
Publicado no Med Decis Making (2016)

Method for evaluating prediction models that apply the results of randomized trials to individual patients

Por Kattan Michael W, Vickers Andrew J, Sargent Daniel J
Publicado em 2007-06-01

A Decision Analysis for Treatment of Clinically Localized Prostate Cancer

Por Kattan, Michael W, Cowen, Mark E, Miles, Brian J
Publicado em 1997

Questioning Decision Analysis for Treatment of Clinically Localized Prostate Cancer

Por Kattan, Michael W, Cowen, Mark E, Miles, Brian J
Publicado em 1997

The REDUCE metagram: a comprehensive prediction tool for determining the utility of dutasteride chemoprevention in men at risk for prostate cancer

Por Nguyen, Carvell T., Isariyawongse, Brandon, Yu, Changhong, Kattan, Michael W.
Publicado em 2012

Prognostic Nomogram for Patients Undergoing Resection for Adenocarcinoma of the Pancreas

Por Brennan, Murray F., Kattan, Michael W., Klimstra, David, Conlon, Kevin
Publicado em 2004

Minimally Invasive Therapy for Prostate Cancer: Use of Nomograms to Counsel Patients about the Choice and Probable Outcome of Therapy

Por Slawin, Kevin M, DiBlasio, Christopher J, Kattan, Michael W
Publicado em 2004

Gleason grade remains an important prognostic predictor in men diagnosed with prostate cancer while on finasteride therapy

Por CARVER, BRETT S., KATTAN, MICHAEL W., SCARDINO, PETER T., EASTHAM, JAMES A.
Publicado em 2005

Adding propensity scores to pure prediction models fails to improve predictive performance

Por Nowacki, Amy S., Wells, Brian J., Yu, Changhong, Kattan, Michael W.
Publicado em 2013

Comparative Effectiveness of Screening Strategies for Lynch Syndrome

Por Barzi, Afsaneh, Sadeghi, Sarmad, Kattan, Michael W., Meropol, Neal J.
Publicado no J Natl Cancer Inst (2015)

Response to Comment on: Pantalone et al. The Risk of Overall Mortality in Patients With Type 2 Diabetes Receiving Glipizide, Glyburide, or Glimepiride Monotherapy: A Retrospective...

Por Pantalone, Kevin M., Kattan, Michael W., Wells, Brian J., Zimmerman, Robert S.
Publicado em 2011